Provider?s Clinical Support System ? Medication Assisted Treatment Grant

The purpose of this SAMHSA grant program is to expand training for primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and the treatment of chronic pain, increase understanding of the importance of medication-assisted treatment (MAT) and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders. The key aspects of this opportunity include: • Eligibility is limited to national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA-approved schedule III medications for the addictive disorders. • The grant program aims to increase access to medication-assisted treatment (MAT) through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders. • The grant program will provide funding for training primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and the treatment of chronic pain.